In the current paper, we apply a similar approach towards NPM1-mutated AML cases in a homogenous group of 212 patients with normal karyotype in a single academic center, diagnosed under the same procedures and principles integrated stipulated in the WHO 2016 classification. Here, NPM1 is linked to acute myeloid leukemia.